Relationship Between Molecular Structure and Cytochrome P450−Metabolic Intermediate Complex Formation

This publication has 13 references indexed in Scilit:

• Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat
  Biochemical Pharmacology, 1982
• Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450
  Biochemical Pharmacology, 1981
• Quantitative structure–activity relationships in drug metabolism and disposition: Pharmacokinetics of N-substituted amphetamines in humans
  Journal of Pharmaceutical Sciences, 1980
• Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital
  Biochemical Pharmacology, 1980
• Modification of hepatic microsomal oxidative drug metabolism in rats by the opiate maintenance drugs acetylmethadol, propoxyphene, and methadone
  Life Sciences, 1979
• Published by Elsevier ,1979
• The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics
  Biochemical Pharmacology, 1978
• A new class of inhibitory cytochrome P-450 complexes formed during metabolism: A comparison with amphetamine and SKF 525-A type complexes
  Chemico-Biological Interactions, 1976
• Inhibition of the Metabolism ofN-Substituted Amphetamines by SKF 525-A and Related Compounds
  Xenobiotica, 1974
• Quantitative Relationships Between Lipophilic Character and Drug Metabolism
  Drug Metabolism Reviews, 1972